Learn how the 12-year biologic exclusivity rule under the BPCIA delays biosimilar entry, impacting drug prices and patient access in the US compared to global markets.
Sep, 11 2025
Oct, 19 2025
Dec, 2 2025
Dec, 25 2025
Sep, 30 2025